Trump Urges Congress to Expand Access to Full-Spectrum CBD Products in the U.S.

U.S. President Donald Trump recently sparked renewed discussion around cannabidiol regulation after calling on Congress to modernize existing laws to allow broader access to “full-spectrum” CBD products. In a post shared on Truth Social, Trump emphasized the need for updated legislation that ensures Americans can benefit from the full range of hemp-derived compounds, not just isolated CBD.

Full-spectrum CBD refers to products that contain a variety of naturally occurring cannabinoids, terpenes, and other compounds found in the cannabis plant, including trace amounts of THC within federally legal limits. Advocates argue that these compounds work together in what is known as the “entourage effect,” potentially enhancing the therapeutic benefits of CBD for issues such as anxiety, chronic pain, inflammation, and sleep disorders.

Trump’s statement highlights a growing debate in the U.S. CBD market, where current regulations remain fragmented and often unclear. While the 2018 Farm Bill legalized hemp-derived CBD at the federal level, restrictions and inconsistencies continue to limit consumer access to certain formulations, particularly full-spectrum products. Industry leaders and stakeholders have long pushed for clearer guidelines to support innovation, ensure product safety, and expand market opportunities.

The call for reform also reflects increasing consumer demand for natural wellness solutions. The global CBD market has seen rapid growth, driven by rising awareness of its potential health benefits and shifting public perception of cannabis-related products. However, regulatory uncertainty has slowed progress in areas such as product labeling, quality control, and interstate commerce.

By urging Congress to revisit CBD legislation, Trump has added momentum to ongoing discussions about cannabis policy reform in the United States. Supporters believe that updated laws could strengthen the domestic hemp industry, create jobs, and provide consumers with safer, more effective CBD options. As lawmakers consider potential changes, the future of full-spectrum CBD products in the U.S. remains a closely watched issue for both businesses and consumers alike.